Spectral AI, Inc. (MDAI)

Market Cap	17.78M
Revenue (ttm)	22.53M
Net Income (ttm)	-20.24M
Shares Out	17.61M
EPS (ttm)	-1.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	116,888
Open	1.040
Previous Close	1.040
Day's Range	1.010 - 1.070
52-Week Range	0.824 - 4.680
Beta	0.56
Analysts	Strong Buy
Price Target	4.50 (+345.55%)
Earnings Date	Nov 11, 2024

About MDAI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinici...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 78
• Stock Exchange: NASDAQ
• Ticker Symbol: MDAI
• Website: https://www.spectral-ai.com

Financial Performance

In 2023, Spectral AI's revenue was $18.06 million, a decrease of -28.82% compared to the previous year's $25.37 million. Losses were -$20.85 million, 616.1% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for MDAI stock is "Strong Buy." The 12-month stock price forecast is $4.5, which is an increase of 345.55% from the latest price.

Price Target

$4.5

(345.55% upside)

Analyst Consensus: Strong Buy